Clearmind Medicine (CMND) Tax Provisions (2023 - 2026)
Clearmind Medicine's (CMND) quarterly Tax Provisions came in at -$3311.0 in Q2 2026, up 83.97% on a YoY basis from -$1799.7 in Q2 2025, and up 16.39% quarter-over-quarter from -$3960.0 in Q1 2026.
Powered by 
Analysis
Clearmind Medicine (CMND) Tax Provisions (2023 - 2026) Analysis & Trends
Clearmind Medicine (CMND) has reported Tax Provisions for 4 consecutive years, with -$3311.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Provisions rose 83.97% year-over-year to -$3311.0; the trailing twelve-month figure through Apr 2026 stood at -$17723.0 (up 91.13% YoY), and the FY2025 full-year result was -$70445.0, up 81.36% from the prior year.
- Tax Provisions advanced to -$3311.0 in Q2 2026 per CMND's latest filing, from -$3960.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $6631.0 in Q3 2023 and bottomed at -$201500.0 in Q1 2024.
- Historically, Tax Provisions has averaged -$33616.8 across 4 years, with a median of -$9805.5 in 2023.
- The sharpest annual moves came in 2024 and 2025: Tax Provisions tumbled 5856.25% in 2024, then soared 97.74% in 2025.
- Over 4 years, Tax Provisions stood at -$11353.0 in 2023, then slumped by 755.46% to -$97120.0 in 2024, then jumped by 97.74% to -$2194.0 in 2025, then slumped by 50.91% to -$3311.0 in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered -$3311.0, -$3960.0, and -$2194.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 1.21 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 662.00 Mn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 654.00 Mn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -1.01 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -407.00 Mn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -524.23 Mn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 165.91 Mn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 39.70 Mn |
| 10 | Clearmind Medicine | 14,742.44 | -13.58 Mn | - | -3,311.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -3,311.00 |
| Jan 31, 2026 | -3,960.00 |
| Oct 31, 2025 | -2,194.00 |
| Jul 31, 2025 | -8,258.00 |
| Apr 30, 2025 | -20,658.00 |
| Jan 31, 2025 | -39,335.00 |
| Oct 31, 2024 | -97,120.00 |
| Jul 31, 2024 | -42,590.00 |
| Apr 30, 2024 | -36,756.00 |
| Jan 31, 2024 | -201,500.00 |
| Oct 31, 2023 | -11,353.00 |
| Jul 31, 2023 | 6,631.00 |
| Apr 30, 2023 | -6,848.77 |
| Jan 31, 2023 | -3,383.00 |